LCM
CRL icon

Logan Capital Management’s Charles River Laboratories CRL Stock Holding History

Logan Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,584
Closed -$1.31M – 495
2026
Q1 		$1.31M Buy
+7,584
New +$1.41M 0.06% 195

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Logan Capital Management's CRL Position: Q2 2026 in Review

Logan Capital Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 7,584 shares worth $1.72M. The stake represents 0.06% of the portfolio and ranks #183 among its holdings. This is a return to the name: Logan Capital Management previously reported a position in CRL as recently as Q4 2025.

Logan Capital Management first reported a position in CRL in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.59M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Logan Capital Management held 7,584 shares of Charles River Laboratories worth $1.72M as of Q2 2026.
  • Charles River Laboratories was a new Logan Capital Management position in Q2 2026.
  • Charles River Laboratories made up 0.06% of Logan Capital Management's portfolio in Q2 2026, its #183 holding.
  • Logan Capital Management first reported a position in Charles River Laboratories in Q4 2020 and has held it in 22 quarters since.
  • Logan Capital Management's Charles River Laboratories position peaked at $8.59M in Q3 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Logan Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.